Simonian Nancy A — SEC Form 4 filings

SEC reporting owner CIK 1359574. 6 Form 4 filings on record with FilingPulse; latest filed 2026-03-02.

Transaction summary — filings shown

Covers all 6 filings on record, filed 2024-04-02 to 2026-03-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Syros Pharmaceuticals, Inc. (SYRS)Director52 legs · 171,783 sh · $45,7569
Generate Biomedicines, Inc. (GENB)Director11

Form 4 filings — Simonian Nancy A

FiledFormIssuerReported transactionsSource
2026-03-024Generate Biomedicines, Inc. (GENB)Grant/award (A): 29,561 (derivative) @ $0EDGAR
2024-12-044Syros Pharmaceuticals, Inc. (SYRS)Sale (S): 37,070 @ $0.27EDGAR
2024-11-274Syros Pharmaceuticals, Inc. (SYRS)Sale (S): 134,713 @ $0.27EDGAR
2024-11-044Syros Pharmaceuticals, Inc. (SYRS)Option exercise (M): 40,125 · Option exercise (M): 40,125 (derivative) @ $0EDGAR
2024-06-074Syros Pharmaceuticals, Inc. (SYRS)Grant/award (A): 4,000 @ $0 · Grant/award (A): 6,000 (derivative) @ $0EDGAR
2024-04-024Syros Pharmaceuticals, Inc. (SYRS)Option exercise (M): 6,000 · Option exercise (M): 39,566 · Tax withholding (F): 14,052 @ $5.12 · Option exercise (M): 6,000 (derivative) @ $0 · Option exercise (M): 39,566 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1359574 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →